Matrix metalloproteinases

molecular aspects of their roles in tumour invasion and metastasis

Stephanie Curran, Graeme Ian Murray

Research output: Contribution to journalArticle

474 Citations (Scopus)

Abstract

The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, whose physiological functions include tissue remodelling and embryogenesis. Thc importance of this group of proteins in the processes of tumour invasion and metastasis is now widely acknowledged, and has led to the search for MMP inhibitors for use as anticancer treatments in a clinical setting. This review aims to bring the reader up-to-date with current research relating to MMPs, with particular emphasis on emerging mechanisms of regulation of these enzymes, and their interaction with cell adhesion molecules. The therapeutic inhibition of MMPs will also be discussed. (C) 2000 Elsevier Science Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)1621-1630
Number of pages10
JournalEuropean Journal of Cancer
Volume36
Publication statusPublished - 2000

Keywords

  • matrix metalloproteinase
  • tumour
  • pathology
  • gene regulation
  • GELATINASE-B SECRETION
  • colon cancer cells
  • colorectal cancer
  • tissue inhibitors
  • gastric cancer
  • INTEGRIN ALPHA-V-BETA-3
  • STROMELYSIN-1 MMP-3
  • breast carcinoma
  • poor prognosis
  • human melanoma

Cite this

Matrix metalloproteinases : molecular aspects of their roles in tumour invasion and metastasis. / Curran, Stephanie; Murray, Graeme Ian.

In: European Journal of Cancer, Vol. 36, 2000, p. 1621-1630.

Research output: Contribution to journalArticle

@article{00b281d48fd5426ea2845186ee38143c,
title = "Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis",
abstract = "The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, whose physiological functions include tissue remodelling and embryogenesis. Thc importance of this group of proteins in the processes of tumour invasion and metastasis is now widely acknowledged, and has led to the search for MMP inhibitors for use as anticancer treatments in a clinical setting. This review aims to bring the reader up-to-date with current research relating to MMPs, with particular emphasis on emerging mechanisms of regulation of these enzymes, and their interaction with cell adhesion molecules. The therapeutic inhibition of MMPs will also be discussed. (C) 2000 Elsevier Science Ltd. All rights reserved.",
keywords = "matrix metalloproteinase, tumour, pathology, gene regulation, GELATINASE-B SECRETION, colon cancer cells, colorectal cancer, tissue inhibitors, gastric cancer, INTEGRIN ALPHA-V-BETA-3, STROMELYSIN-1 MMP-3, breast carcinoma, poor prognosis, human melanoma",
author = "Stephanie Curran and Murray, {Graeme Ian}",
year = "2000",
language = "English",
volume = "36",
pages = "1621--1630",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER APPL SCI PUBL LTD",

}

TY - JOUR

T1 - Matrix metalloproteinases

T2 - molecular aspects of their roles in tumour invasion and metastasis

AU - Curran, Stephanie

AU - Murray, Graeme Ian

PY - 2000

Y1 - 2000

N2 - The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, whose physiological functions include tissue remodelling and embryogenesis. Thc importance of this group of proteins in the processes of tumour invasion and metastasis is now widely acknowledged, and has led to the search for MMP inhibitors for use as anticancer treatments in a clinical setting. This review aims to bring the reader up-to-date with current research relating to MMPs, with particular emphasis on emerging mechanisms of regulation of these enzymes, and their interaction with cell adhesion molecules. The therapeutic inhibition of MMPs will also be discussed. (C) 2000 Elsevier Science Ltd. All rights reserved.

AB - The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes, whose physiological functions include tissue remodelling and embryogenesis. Thc importance of this group of proteins in the processes of tumour invasion and metastasis is now widely acknowledged, and has led to the search for MMP inhibitors for use as anticancer treatments in a clinical setting. This review aims to bring the reader up-to-date with current research relating to MMPs, with particular emphasis on emerging mechanisms of regulation of these enzymes, and their interaction with cell adhesion molecules. The therapeutic inhibition of MMPs will also be discussed. (C) 2000 Elsevier Science Ltd. All rights reserved.

KW - matrix metalloproteinase

KW - tumour

KW - pathology

KW - gene regulation

KW - GELATINASE-B SECRETION

KW - colon cancer cells

KW - colorectal cancer

KW - tissue inhibitors

KW - gastric cancer

KW - INTEGRIN ALPHA-V-BETA-3

KW - STROMELYSIN-1 MMP-3

KW - breast carcinoma

KW - poor prognosis

KW - human melanoma

M3 - Article

VL - 36

SP - 1621

EP - 1630

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -